Expert Resources: Reports
Expert Resources: Report
This section contains major reports about counterfeit medicines, internet-based medicines operations, and other related threats that put consumers at risk of acquiring fake or contraband medicines. All of these reports are either in the public domain or available from the host website.
For general information on counterfeit medicines, see WHO Fact Sheet No 275, FDA Fact Sheets, or Wikipedia. To learn about the U.S. situation specifically, visit WebMD’s online feature: “Counterfeit Drugs: A Rising Public Health Problem.”
2006
NEW! Pfizer. Safeguarding the integrity of the
medicines supply chain in Europe. September 2006.
NEW! American Council on Science and Health. Counterfeit Drugs: Coming to a Pharmacy Near You. August 2006.
Stockholm Network. Coincidence or Crisis? Prescription Medicine Counterfeiting. July 2006.
U.S. FDA. FDA Counterfeit Drug Task Force Report. June 2006.
Campaign for Fighting Diseases. Counterfeit medicines in less
developed countries. May 2006.
Liang, Bryan A. “The Scourge of Counterfeit Drugs: No Easy Answers,” 9(2) JOURNAL OF BIOLAW & BUSINESS 3-7 (2006).
Liang, Bryan A. “Fade to Black: Importation and the Risks of Counterfeit Medicines,” 32 AMERICAN JOURNAL OF LAW & MEDICINE 279-323 (2006).
Liang, Bryan A. “Parallel Trade in Pharmaceuticals: Injecting the Counterfeit Element into the Public’s Health,” 31(4)
NORTH CAROLINA JOURNAL OF INT’L LAW AND COMMERCIAL REGULATION 847-899 (2006).
2005
Health Canada.
Developing a Drug Supply Network and an Export Restriction Scheme.
November 2005.
Harper, Jonathan. Counterfeit Medicines & Pharmaceutical Crime
in Europe: “Invisibility, Biohazard & System Failure”. September 2005.
Council of Europe. Counterfeit medicines – Survey Report. July 2005.
Centre for Reform (U.K.). Illegal Online Pharmacies put Patients at Grave Risk Unless Government Takes Action. 30 August 2005.
U.S. FDA. Annual Update-2005 Plan
to Fight Counterfeit Drugs. May 2005.
Giuliani Partners, LLC. EXAMINATION AND ASSESSMENT OF PRESCRIPTION DRUG IMPORTATION FROM FOREIGN SOURCES TO THE UNITED STATES. April 2005.
Cockburn, Robert et al. “The Global Threat of Counterfeit Drugs:
Why Industry and Governments Must Communicate the Dangers”. PLoS Medicine 2:4 (April 2005): 100-106.
Alabdalla, Mahmoud A. “Chemical characterization of counterfeit captagon tablets seized in Jordan.” Forensic Science International 152 (2005): 185-188.
Blok-Tip, L. et al. “Counterfeits and imitations of Viagra® and Cialis® tablets: trends and risks to public health.” RIVM Report 267041001/2005. 36 pp.
Halser, Jennifer L. “Canadian Pharmacies: A Prescription for a Public Health Disaster.” DePaul Law Review. 54 (Winter 2005): 543-587.
Liang, Bryan A. “Over the Virtual and Geographic Borders: Understanding Importation and Counterfeit Drugs,” 36
CALIFORNIA WESTERN INTERNATIONAL LAW JOURNAL 7-18 (2005) [reprinted in “Selected Essays and Transcripts from
the Institute of Health Law Studies Conference on International Drug Importation: Issues in Public Policy, Patient
Safety, and the Public Health,” CALIFORNIA WESTERN LAW REVIEW/ INTERNATIONAL LAW JOURNAL SPECIAL EDITION (2005)].
Liang, Bryan A. “Introduction: International Drug Importation: Issues in Public Policy, Patient Safety, and the Public
Health,” 36 CALIFORNIA WESTERN INTERNATIONAL LAW JOURNAL 1-6 (2005).
Liang, Bryan A. “Importation and Counterfeit Drugs: Concurrent Concerns for Seniors,” 15(4) EXPERIENCE 6-10
(Summer 2005).
Liang, Bryan A. “Shades of Gray: Counterfeit Drugs,” SAN DIEGO LAWYER 29-31 (September/October 2005).
Liang, Bryan A. “No Shortcuts to Health and Safety: The Threat of Counterfeit Drugs,” 92(3) SAN DIEGO PHYSICIAN 10-11 (March 2005).
2004
U.S. Department of Health and Human Services. Report on Prescription Drug Importation. December 2004.
Satchwell, Graham. A Sick Business: Counterfeit Medicines and Organised Crime. London: Stockholm Network, 2004.
Office of National Drug Control Policy. National Synthetic Drugs Action Plan. October 2004.
National Center on Addicition and Substance Abuse at Columbia University. You’ve Got Drugs! Prescription Drug Pushers on the Internet. October 2004.
Food and Drug Administration. FDA
Test Results of Prescription Drugs from Bogus Canadian Website Show All Products
Are Fake and Substandard. 13 June 2004
General Accounting Office. INTERNET PHARMACIES: Some Pose Safety Risks for Consumers. Report
to the Chairman, Permanent Subcommittee on Investigations, Committee on Governmental
Affairs, U.S. Senate. June 2004.
U.S. FDA. Report on Plan
to Fight Counterfeit Drugs. February 2004.
Croonen, Heleen, ed. “Nep-Cialis bevat sildenafil.” Pharmaceutisch Weekblad. 139:40 (1 Oct 2004): 1300-1302.
Lybecker, Kristina M. Parallel Imports & Innovation:
The Economics of Reimportation and The Economics of Reimportation and
Counterfeit Pharmaceuticals. March 9, 2004. See also “Economics of reimportation and risks of counterfeit pharmaceuticals,” Managed Care. (2004 Mar) 13(3 Suppl):10-3.
Meyers, Craig. “The Application of Civil RICO Laws to Rogue Internet Pharmacies.” Journal of High Technology Law. 4 (2004): 191-208.
Rosenfield, Todd A. “The Counterfeit Drug Invasion: How Drug Re-Importation Unjustifiably Poses a Threat to the Health of the U.S. Public.” University of Pennsylvania Journal of International Economic Law 25:3 (Fall 2004): 1047-1077.
Saiger, Abraham N. “In Search of a Government that Will Govern: Senate Bill 812 and “Reimporting” Prescription Medication from Canada.” Elder Law Journal 12 (2004): 177-223.
Shepherd, MD. “Vulnerable Points in the U.S. Drug Distribution System,” Supplement to Managed Care 13:3 (March 2004): 25-29.
Shepherd, MD “Canada Cannot Meet US Drug Supply Needs” Product Management Today (July 2004).
Shepherd, MD, “Counterfeit Medications and the Pharmacist’s Responsibilities,. CE Solutions (December 1, 2004): 1-12.
Shepherd, MD, “Drug Quality: Safety Issues and Threats of Drug Importation,” California Western Law Review/International Law Journal, Special Edition, (Summer 2005): 77-88.
Stearn, Douglas W. “Deterring the Importation of Counterfeit Pharmaceutical Products.” Food and Drug Law Journal 59 (2004): 537-561.
2003
Florida State Legislature, Office of Program Policy Analysis and Government Accountability. Counterfeit and Diverted Drugs Threaten Public Health and Waste State Dollars. February 2003. Report No. 03-18.
State Supreme Court of Florida. FIRST INTERIM REPORT
OF THE
SEVENTEENTH STATEWIDE GRAND JURY.
DeKieffer, Don. The Mexican Connection: How Trade in Pharmaceuticals Wrecked the FDA. Southwestern Journal of Law and Trade in the Americas IX:2 (2002-2003): 321-330.
Global Options, An Analysis of Terrorist Threats to America’s Medicine Supply. 2003.
Kontnik, Lew. Counterfeiting: the Cost of Combat. Pharmaceutical Executive (November 1 2003).
Lybercker, Kristina M. Product Piracy: the Sale of Counterfeit Pharmaceuticals in Developing Countries. January 2003.
Moken, Merri C. “Fake Pharmaceuticals: How They and Relevant Legislation or Lack Thereof Contribute to Consistently High and Increasing Drug Prices.” American Journal of Law and Medicine. 29 (2003): 525-542.
Creanza NC and Shepherd, MD, “Understanding prescription Drug Importation” Supplement to Pharmacy Today ( November 2003): 1-11.
Rudolf, Paul M. and Ilisa B.G. Bernstein, “Counterfeit Drugs,” New England Journal of Medicine 350:14 (April 1, 2004).
Shepherd, MD., “Threat of Drug Importation” Texas Pharmacy ( Winter 2003): 5-7, 10,11.
2002
Browning, Tim. “Strategies to deter counterfeiting of pharmaceutical drugs in China, Part II.” South China Business Journal (July/August 2002): 10-14.
Browning, Tim. “Strategies to deter counterfeiting of pharmaceutical drugs in China, Part I.” South China Business Journal (June 2002): 5-8.
2001
Shepherd M.D. “Concern about Foreign Source Pharmacy Internet Providers,” Journal of Managed Care Pharmacy, 7(5) (September/October 2001): 335-336.
Pre-2000
Shepherd, M.D. Final Report, “Examination of the Type and Amount of Pharmaceutical Products Being Declared by U.S. Residents Upon Returning to the U.S. from Mexico at the Laredo, TX, Border Crossing,” submitted to the National Association of Chain Drug Stores, Alexandria, VA, and Texas Pharmacy Foundation, Austin, TX.
McKeithan, E. K. and Shepherd, M.. D., “Pharmaceutical Products Declared by U.S. Residents on Returning to the United States from Mexico,” Clinical Therapeutics, Vol. 18, No. 6, (November-December 1996), pp 1242-1251.